SYNTHESIS AND BIOLOGICAL EVALUATION OF 1-[1-(2-BENZO[B]THIENYL)CYCLOHEXYL]PIPERIDINE HOMOLOGS AT DOPAMINE-UPTAKE AND PHENCYCLIDINE-BINDING AND SIGMA-BINDING SITES
Xs. He et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF 1-[1-(2-BENZO[B]THIENYL)CYCLOHEXYL]PIPERIDINE HOMOLOGS AT DOPAMINE-UPTAKE AND PHENCYCLIDINE-BINDING AND SIGMA-BINDING SITES, Journal of medicinal chemistry, 36(9), 1993, pp. 1188-1193
Piperidine and cyclohexyl ring homologues of the high-affinity dopamin
e (DA) uptake inhibitor 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
(BTCP, 3) were each prepared in four steps from the appropriate cycloa
lkanones. These compounds were tested for their ability to displace [H
-3]-BTCP and [H-3]cocaine and to inhibit [H-3]DA uptake in rat striata
l homogenates. The ratios IC50([H-3]cocaine)/IC50 ([H-3]BTCP) ranged f
rom 62 for BTCP to 1.5 for 1-[2-(benzo[b]thienyl)-cyclopentylamine (17
); cocaine gave a ratio of 0.6. This indicates that BTCP is the most s
elective of all the compounds tested for sites labeled by [H-3]BTCP wh
ereas cocaine is most selective for sites labeled by [H-3]cocaine. The
wide differences in the relative abilities of these compounds to disp
lace [H-3]BTCP and [H-3]cocaine suggests that these two radioligands a
re labeling different sites on the transporter. In general, the compou
nds structurally related to BTCP exhibited greater selectivity for sit
es labeled by [H-3]BTCP. However, several of the BTCP-related derivati
ves showed greater (compared with BTCP and cocaine) ability to displac
e [H-3]cocaine. Most notably, 1-[1-(2-benzo[b]thienyl)cyclohexyl]pyrro
lidine (7) exhibited a 3.4-fold greater affinity for these sites compa
red with BTCP and a 9-fold greater affinity at these sites than cocain
e. Most of the BTCP homologues displayed greater ability to inhibit[H-
3]DA uptake in rat forebrain synaptosomes than cocaine. BTCP and 7 wer
e the most potent of all the compounds tested in terms of their abilit
y to inhibit uptake of [H-3]DA. IC50 ratios for [H-3]cocaine binding/[
H-3]DA uptake ranged from 0.47 for 1-[1-(2-benzo[b]thienyl)cyclopentyl
]homopiperidine (11) to 8.8 for 1-(2-benzo[b]-thienyl)cyclohexylamine(
4). The importance of this ratio remains unclear in terms of identific
ation of potential cocaine antagonists. As for BTCP, all of the compou
nds tested showed K(i) values > 10 000 nM for displacement of [H-3]TCP
from rat brain homogenates. These compounds were able to displace the
highly selective a receptor probe [H-3]-(+)-pentazocine from guinea p
ig brain homogenates with K(i) values ranging from 125 to 9170 nM. The
significance of their sigma-binding activity in light of their dopami
nergic properties is unclear. The diverse binding properties of these
compounds at the DA-uptake site and their spectrum of inhibitory activ
ities for [H-3]DA uptake identifies them as a useful base for the deve
lopment of subtype selective probes at this site. These compounds will
allow further study of the structure and function of the ''cocaine' r
eceptor as well as the development of potential cocaine antagonists.